Venebio Group, LLC is the parent company of Venebio Consulting, a global life sciences consultant network, and Venebio Technologies, a developer of personalized clinical decision support tools targeting areas of unmet human health needs.

Venebio Consulting

Venebio delivers scalable, comprehensive scientific problem solving and project management support in:

  • Epidemiology, Biostatistics, Advanced Analytics, and Real-World Evidence
  • Systematic Review and Scientific Writing
  • Precision Medicine
  • Drug/Device Development and Safety
  • Scientific Litigation Support
  • Health Economics and Outcomes Research (HEOR)

Pulling from Venebio’s core team of principal scientists and a global network of consultants, our project teams are assembled to provide the exact expertise and skillsets necessary to meet your needs.

Venebio Technologies

Venebio Technologies develops and commercializes unique clinical decision support (CDS) tools that provide clinicians with up-to-date, evidence-based guidance to enhance medication adherence and population health. Venebio’s patient-specific, algorithm-based tools help clinicians immediately identify the most effective drug and dosage regimen for each patient.

Currently, Venebio offers two CDS tools: Venebio Opioid Advisor and Venebio Statin Advisor.  Each offers precise, personalized health care guidance, which ultimately can reduce health care costs, make clinician time more efficient, and allow treatment goals to be attained faster.

Case Studies

“The acceptance and publication of this manuscript allowed Venebio to assist in increasing market awareness of the client’s product, and provide business and marketing strategy guidance to the client.”
View Full Case Study
“Regulatory engagement of any kind requires a diverse and nuanced skillset with an understanding of regulatory history, evolving current practices, clinical strategy and scientific writing. Venebio’s in-depth understanding of regulatory requirements, as well as our team’s experience in drafting agency-facing reports, was an essential part of this first-of-its-kind application.”
View Full Case Study
“Systematic reviews and meta-analyses often include only randomized controlled trials as sources of evidence. In this systematic review, Venebio’s inclusion of other study designs—and the appropriate methodological handling of them—increased the combined sample size and the generalizability of results. Bringing this to the scientific community allowed the client to increase market visibility and better position its drug as the ideal treatment option.”
View Full Case Study
“Complex research questions require a multifaceted approach. Quantitative data can be complex, and a client’s ability to assemble an effective, efficient analytic team in-house is sometimes limited. Outsourcing to a lean but experienced group of well-rounded researchers is often the fastest, most cost-effective option. ”
View Full Case Study
“The issues surrounding the nation’s opioid epidemic are not going away any time soon. In addition to national awareness and crisis response, prevention is essential. When asked to analyze and determine risk factors for opioid overdose, Venebio took it one step further to develop a clinical decision support tool that provides personalized overdose risk information.”
View Full Case Study
“The acceptance and publication of this manuscript allowed Venebio to assist in increasing market awareness of the client’s product, and provide business and marketing strategy guidance to the client.”
View Full Case Study
“Regulatory engagement of any kind requires a diverse and nuanced skillset with an understanding of regulatory history, evolving current practices, clinical strategy and scientific writing. Venebio’s in-depth understanding of regulatory requirements, as well as our team’s experience in drafting agency-facing reports, was an essential part of this first-of-its-kind application.”
View Full Case Study
“Systematic reviews and meta-analyses often include only randomized controlled trials as sources of evidence. In this systematic review, Venebio’s inclusion of other study designs—and the appropriate methodological handling of them—increased the combined sample size and the generalizability of results. Bringing this to the scientific community allowed the client to increase market visibility and better position its drug as the ideal treatment option.”
View Full Case Study
“Complex research questions require a multifaceted approach. Quantitative data can be complex, and a client’s ability to assemble an effective, efficient analytic team in-house is sometimes limited. Outsourcing to a lean but experienced group of well-rounded researchers is often the fastest, most cost-effective option. ”
View Full Case Study
“The issues surrounding the nation’s opioid epidemic are not going away any time soon. In addition to national awareness and crisis response, prevention is essential. When asked to analyze and determine risk factors for opioid overdose, Venebio took it one step further to develop a clinical decision support tool that provides personalized overdose risk information.”
View Full Case Study

Select Clients

Indivior MWV VCU NIH NIH The Medicines Company Lineagen Bristol-Myers Squibb Baxalta